Inventor · disambiguated record
Atsushi Kuno
Also filed as: KUNO ATSUSHI
23 granted patents·9 pending applications·178 citations·filing 1985–2019
95Inventor score
Files withFUJISAWA PHARMACEUTICAL CO11AIST5NARIMATSU HISASHI4HIRABAYASHI JUN2NAT INST ADVANCED IND SCIENCE & TECH2
Top patents by PatentIndex Score
32 records- 0182US9500650B2Undifferentiated cell detection method and complex carbohydrate detection methodNAT INST ADVANCED IND SCIENCE & TECH·Filed 2012·Granted Nov 22, 2016·5 cites·15 claims
- 0278US8623608B2Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver diseaseNARIMATSU HISASHI·Filed 2012·Granted Jan 7, 2014·3 cites·13 claims
- 0377US4727073APyrimidine derivatives and composition of the sameFUJISAWA PHARMACEUTICAL CO·Filed 1985·Granted Feb 23, 1988·14 cites·11 claims
- 0475US4857527AMorpholine containing pyridine compounds, compositions and useFUJISAWA PHARMACEUTICAL CO·Filed 1988·Granted Aug 15, 1989·12 cites·7 claims
- 0575US4698340APyrimidine derivatives, processes for preparation thereof and composition containing the sameFUJISAWA PHARMACEUTICAL CO·Filed 1985·Granted Oct 6, 1987·23 cites·15 claims
- 0674US11571473B2Method for efficiently inducing antibody, antibody and detection system for hepatitis virusAIST·Filed 2019·Granted Feb 7, 2023·1 cites·9 claims
- 0774US9696320B2Lung cancer differential markerNARIMATSU HISASHI·Filed 2011·Granted Jul 4, 2017·3 cites·4 claims
- 0873US5824691AGuanidine derivatives as inhibitors of Na+ /H+ exchange in cellsFUJISAWA PHARMACEUTICAL CO·Filed 1994·Granted Oct 20, 1998·32 cites·12 claims
- 0972US9796761B2Glycan markers as measure of disease state of hepatic diseasesNARIMATSU HISASHI·Filed 2010·Granted Oct 24, 2017·3 cites·5 claims
- 1072US5622976AOxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activityFUJISAWA PHARMACEUTICAL CO·Filed 1992·Granted Apr 22, 1997·28 cites·7 claims
- 1168US5059608ABicyclic amine compound and a process for the preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1989·Granted Oct 22, 1991·14 cites·14 claims
- 1267US4990507AN-containing heterocyclic compounds, and composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1989·Granted Feb 5, 1991·8 cites·5 claims
- 1366US5037824AN-containing heterocyclic compounds, compositions and useFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Aug 6, 1991·10 cites·6 claims
- 1460US4831030ADiphenylpyridine compounds, processes for the preparation thereof and composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1986·Granted May 16, 1989·8 cites·5 claims
- 1559US2018106814A1Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver diseaseSYSMEX CORP·Filed 2017·Application pending·0 cites
- 1656US10539576B2Lung cancer differential markerAIST·Filed 2017·Granted Jan 21, 2020·0 cites·4 claims
- 1756US4931453ADi phenylpyridazine compounds, processes for the preparation thereof and pharmaceutical compositions comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1988·Granted Jun 5, 1990·6 cites·6 claims
- 1856US2014057286A1Method for Measuring Glycoprotein, Method for Examining Liver Desease, Reagent for Quantitative Determination of Glycoprotein and Glycan-Marker Glycoprotein as an Index for Clinical Conditions of Liver DiseaseSYSMEX CORP·Filed 2013·Application pending·0 cites
- 1952US10156576B2Method for enrichment and separation of spinal fluid glycoprotein, method for searching for marker for central nervous system diseases which utilizes the aforementioned method, and marker for central nervous system diseasesAIST·Filed 2016·Granted Dec 18, 2018·0 cites·9 claims
- 2048US2014323324A1Method for Enrichment and Separation of Spinal Fluid Glycoprotein, Method for Searching for Marker for Central Nervous System Diseases Which Utilizes the Aforementioned Method, and Marker for Central Nervous System DiseasesNARIMATSU HISASHI·Filed 2011·Application pending·0 cites
- 2147US8008094B2Methods for analyzing interactions between proteins and sugar chainsNAT INST OF ADVANCED IND SCIEN·Filed 2004·Granted Aug 30, 2011·0 cites·13 claims
- 2245US2007298485A1Method for Separation of Glycosaminoglycan From Core Protein of Proteoglycan with the Use of XylanaseTAKAGAKI KEIICHI·Filed 2003·Application pending·0 cites
- 2344US2009041630A1Analyzer for glycan or complex carbohydrateNAT INST OF ADVANCED IND SCIEN·Filed 2006·Application pending·0 cites
- 2443US5968985ABenzoylguanidine derivatives as medicamentsFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Oct 19, 1999·6 cites·12 claims
- 2541US10352927B2Glycoform detection method and glycoform detection deviceAIST·Filed 2013·Granted Jul 16, 2019·0 cites·13 claims
- 2641US2007167608A1Sugar chain structure profiling techniquesHIRABAYASHI JUN·Filed 2004·Application pending·0 cites
- 2740US8597576B2Analyzer for glycan or complex carbohydrateHIRABAYASHI JUN·Filed 2011·Granted Dec 3, 2013·0 cites·21 claims
- 2839US2017336413A1Rheumatoid arthritis markerAIST·Filed 2015·Application pending·0 cites
- 2939US2015293104A1Epithelial ovarian cancer differentiation markerNOZAKI HIROFUMI·Filed 2012·Application pending·0 cites
- 3038US2017219590A1Hepatocellular carcinoma markerNAT INST ADVANCED IND SCIENCE & TECH·Filed 2015·Application pending·0 cites
- 3135US6017917AGuanidine derivativesFUJISAWA PHARAMCEUTICAL CO LTD·Filed 1996·Granted Jan 25, 2000·2 cites·9 claims
- 3234US8557602B2Method for detecting and distinguishing intrahepatic cholangiocarcinomaKUNO ATSUSHI·Filed 2010·Granted Oct 15, 2013·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Atsushi Kuno files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →